top of page
< Back

Granisetron

格拉司瓊

Mechanism of action:

Granisetron 是一種選擇性血清素 5-HT₃ 受體拮抗劑(selective 5-HT₃ receptor antagonist)。化療或放療會刺激腸道的腸嗜鉻細胞(enterochromaffin cells)釋放大量血清素(5-HT),血清素活化迷走神經上的 5-HT₃ 受體後,會將嘔吐訊號傳送至中樞神經。Granisetron 能結合與阻斷 5-HT₃ 受體,抑制 5-HT₃ 受體介導的迷走傳入訊號,降低嘔吐反射路徑的活化。

​Reference(s):

1. Gan TJ et al. (2005). Selective serotonin 5-HT3 receptor antagonists for postoperative nausea and vomiting: are they all the same? CNS Drugs. 


2. Tan M et al. (2003). Granisetron: new insights into its use for the treatment of chemotherapy-induced nausea and vomiting. Expert Opin Pharmacother. 


3. Feyer P et al. (2005). Granisetron in the control of radiotherapy-induced nausea and vomiting: a comparison with other antiemetic therapies. Support Care Cancer.

bottom of page